---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-010423"
form_type: "8-K"
ticker: "DWTX"
cik: "0001818844"
company_name: "Dogwood Therapeutics, Inc."
filed_at: "2023-05-25T23:59:59+00:00"
generated_at: "2026-06-14T14:52:47.406354+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: "high"
source: SEC EDGAR
---

# Virios Therapeutics regains Nasdaq minimum bid price compliance

## Summary
- Received Nasdaq letter on May 24, 2023 confirming compliance with Listing Rule 5550(a)(2).
- Closing bid price was at least $1.00 for ten consecutive business days (May 10–May 23, 2023).
- Closes the deficiency notice initially received on November 1, 2022 regarding bid price non-compliance.

## SEC filing metadata
- accession: 0001558370-23-010423
- form_type: 8-K
- ticker: DWTX
- cik: 0001818844
- company_name: Dogwood Therapeutics, Inc.
- filed_at: 2023-05-25T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.4
- calibrated_materiality_score: 0.4
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1818844/000155837023010423/0001558370-23-010423-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1818844/000155837023010423/tmb-20230524x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-010423
- JSON: https://secwatch.observer/filing/0001558370-23-010423.json
- Plain text: https://secwatch.observer/filing/0001558370-23-010423.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.